| Rachael A O'neil, | |
|
435 S Main St, Manchester, NH 03102-4841 | |
| (603) 666-5982 | |
| (603) 621-3492 |
| Full Name | Rachael A O'neil |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 435 S Main St, Manchester, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073013371 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | P-0996 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachael A O'neil, 555 Auburn St, Manchester, NH 03103-4803 Ph: (603) 621-3516 | Rachael A O'neil, 435 S Main St, Manchester, NH 03102-4841 Ph: (603) 666-5982 |
News Archive
Toxic Shock Syndrome (TSS) is a severe circulatory and organ failure caused by bacterial toxins, usually triggered by bacteria from the Staphylococcus group. Researchers from MedUni Vienna's Department of Clinical Pharmacology, in collaboration with the company Biomedizinische Forschungsgesellschaft mbH in Vienna, have now developed the world's first safe and effective vaccine against this disease and successfully tested it in a Phase I trial.
The U.S. Food and Drug Administration has approved a name change for the heartburn drug Kapidex (dexlansoprazole) to avoid confusion with two other medications – Casodex and Kadian. Effective in late April 2010, Takeda Pharmaceuticals North America Inc. will market Kapidex under the new name Dexilant.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) Small Business Innovation Research grant (SBIR) for a program on "Clinical Vector for TCR Immunotherapy Targeted to Melanoma". In this program, Lentigen will collaborate with Dr. Michael Nishimura, Professor of Surgery, at the Medical University of South Carolina (MUSC).
The Nalanda Institute announced that enrollment is now open for their inaugural Certificate Program in Contemplative Psychotherapy to begin in Fall 2013. The program offers therapists, health workers, coaches, educators and other professionals in the healing arts an opportunity to immerse themselves in the inspiring new field of contemplative neuropsychology.
Analytic software developed by orthopedic trauma surgeons at NYU Langone Health accurately identifies which middle-aged and elderly patients face a greater mortality risk following surgery for an orthopedic fracture, according to a new study.
› Verified 7 days ago
Kimberly Sexton Judlin, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 655 S Willow St Ste 128, Manchester, NH 03103 Phone: 800-995-2673 | |
Allison Mathieu, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 555 Auburn St, Manchester, NH 03103 Phone: 603-623-8863 | |
Mrs. Kathryn Dickovick Lambert, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Jack Lovering Dr, Manchester, NH 03109 Phone: 603-624-6330 | |
Joyce Ann Santostefano, M.S. CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 769 S Main St, Suite 201, Manchester, NH 03102 Phone: 603-641-6700 Fax: 603-623-3611 | |
Mrs. Denise Lorraine Carter, MST COMM. DIS. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 195 Mcgregor St, Manchester, NH 03102 Phone: 603-660-3296 | |
Nikki Fitzgerald, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3000 Goffs Falls Rd Ste 101, Manchester, NH 03103 Phone: 800-995-2673 | |
Anna Wood, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3000 Goffs Falls Rd Ste 101, Manchester, NH 03103 Phone: 800-995-2673 Fax: 800-995-2673 |